A detailed history of Affinity Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Affinity Wealth Management LLC holds 12,798 shares of LLY stock, worth $11.4 Million. This represents 2.33% of its overall portfolio holdings.

Number of Shares
12,798
Previous 13,130 2.53%
Holding current value
$11.4 Million
Previous $10.2 Million 13.44%
% of portfolio
2.33%
Previous 2.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$724.87 - $909.04 $240,656 - $301,801
-332 Reduced 2.53%
12,798 $11.6 Million
Q1 2024

Apr 18, 2024

SELL
$592.2 - $792.28 $53,890 - $72,097
-91 Reduced 0.69%
13,130 $10.2 Million
Q4 2023

Jan 11, 2024

BUY
$525.19 - $619.13 $160,182 - $188,834
305 Added 2.36%
13,221 $7.71 Million
Q3 2023

Oct 24, 2023

BUY
$434.7 - $599.3 $99,111 - $136,640
228 Added 1.8%
12,916 $6.94 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $34,021 - $45,491
97 Added 0.77%
12,688 $5.95 Million
Q1 2023

May 01, 2023

BUY
$310.63 - $364.82 $100,022 - $117,472
322 Added 2.62%
12,591 $4.32 Million
Q4 2022

Feb 09, 2023

BUY
$321.55 - $374.67 $104,182 - $121,393
324 Added 2.71%
12,269 $4.49 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $28,758 - $32,773
97 Added 0.82%
11,945 $3.86 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $3.3 Million - $3.88 Million
11,848 New
11,848 $3.93 Million
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $210,849 - $243,885
-1,442 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $196,717 - $236,747
1,442 New
1,442 $217,000
Q3 2019

Nov 13, 2019

SELL
$106.79 - $116.16 $262,916 - $285,985
-2,462 Closed
0 $0
Q2 2019

Jul 24, 2019

BUY
$110.79 - $129.32 $18,169 - $21,208
164 Added 7.14%
2,462 $273,000
Q1 2019

May 10, 2019

BUY
$111.31 - $131.02 $255,790 - $301,083
2,298 New
2,298 $298,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $847B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Affinity Wealth Management LLC Portfolio

Follow Affinity Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Wealth Management LLC with notifications on news.